Prolonged stable disease effects survival in patients with solid gastric tumor: analysis of phase II studies of doxifluridine.

International journal of oncology

Volumn 17, Issue 2, 2000, Pages 285-289

  Takahashi, Y ^a   Mai, M ^a   Taguchi, T ^a   Urushizaki, I ^a   Nishioka, K ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIMETABOLITE; DOXIFLURIDINE; FLOXURIDINE;

ARTICLE; DISEASE COURSE; HUMAN; MORTALITY; MULTICENTER STUDY; PHASE 2 CLINICAL TRIAL; STOMACH TUMOR; SURVIVAL;

ANTIMETABOLITES, ANTINEOPLASTIC; CLINICAL TRIALS, PHASE II; DISEASE PROGRESSION; FLOXURIDINE; HUMANS; MULTICENTER STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

MLCS; MLOWN;

EID: 0034244239     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.17.2.285     Document Type: Article

References (0)